Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1–P2 ligands

Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV

(2012) Arun K. Ghosh et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Design, Synthesis, Protein−Ligand X-ray Structure, and Biological Evaluation of a Series of Novel Macrocyclic Human Immunodeficiency Virus-1 Protease Inhibitors to Combat Drug Resistance

(2009) Arun K. Ghosh et al.   JOURNAL OF MEDICINAL CHEMISTRY

Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naive Individuals

(2009) S. Hue et al.   JOURNAL OF VIROLOGY

Emergence of Drug Resistance in HIV Type 1–Infected Patients after Receipt of First‐Line Highly Active Antiretroviral Therapy: A Systematic Review of Clinical Trials

(2008) Ravindra Gupta et al.   CLINICAL INFECTIOUS DISEASES

HAART in treatment-experienced patients in the 21st century: the audacity of hope

(2008) Brian Conway   Future Virology

Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance

(2007) Arun K. Ghosh et al.   ACCOUNTS OF CHEMICAL RESEARCH